Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Kaandorp, Stef ^a   Di Nisio, Marcello ^a   Goddijn, Mariette ^a   Middeldorp, Saskia ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Abortion, habitual *drug therapy; etiology ; Anticoagulants *therapeutic use ; Antiphospholipid syndrome complications ; Aspirin therapeutic use ; Female; Heparin, low molecular weight therapeutic use ; Humans; Pregnancy; Pregnancy complications, hematologic * drug therapy; etiology ; Randomized controlled trials as topic; Thrombophilia complications; *drug therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MULTIVITAMIN; NADROPARIN; PLACEBO; PROSTACYCLIN; THROMBOXANE A2;

AMENORRHEA; ANTIPHOSPHOLIPID SYNDROME; BIRTH RATE; BIRTH WEIGHT; BLEEDING; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONVULSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; FETUS HEART RATE; FETUS MALFORMATION; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HYPERCOAGULABILITY; HYPOGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; LIVE BIRTH; LOW DRUG DOSE; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; PATIENT SELECTION; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; RECURRENT ABORTION; REVIEW; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; TESTIS NECROSIS; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS; TRICUSPID VALVE REGURGITATION; UMBILICAL CORD BLOOD; UNSPECIFIED SIDE EFFECT; UTERUS BLOOD FLOW; VAGINA ATRESIA;

EID: 70249114038     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004734.pub3     Document Type: Review

References (74)

1. Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertility and Sterility 2006;86(2):362-366 (Pubitemid 44118966)
2. Tulppala M, Marttunen M, Soderstrom-Anttila V, Ailus K, Palosuo T, Ylikorkala O. Low dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction 1997;12(1):191. (Pubitemid 27373218)
3. Tulppala M, Marttunen M, Soderstrom-Anttila V, Foudila T, Ailus K, Palosuo T, et al.Low-dose aspirin in the prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human Reproduction 1997;12(7):1567-1572 (Pubitemid 27373218)
4. Bar J, Cohen-Sacher B, Hod M, Blickstein D, Lahav J, Merlob P. Low molecular-weight heparin for thrombophilia in pregnant women. International Journal of Gynecology & Obstetrics 2000;69:209-213 (Pubitemid 30330972)
5. Bar J, Mashiah R, Cohen-Sacher B, Hod M, Orvieto R, Ben-Rafael Z, et al.Effect of thromboprophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thrombosis Research 2001;101:235-241 (Pubitemid 32206578)
6. Bick RL. Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group. Clinical and Applied Thrombosis/Hemostasis 2000;6(3):115-125
7. Brenner B, Hoffman, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thrombosis and Haemostasis 2000;83:693-697 (Pubitemid 30248516)
8. Brenner B, Bar J, Ellis M, Yarom I, Yohai D, Samueloff A. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertility and Sterility 2005;84(3):770-773 (Pubitemid 41317747)
9. Brenner B, for the LIVE-ENOX Investigators. Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss. The LIVE-ENOX study. Blood 2002;100(11 Pt 1):702a.
10. Brenner B, Hoffman R, Carp H, Dulitsky M, Samueloff A, Yohal D, et al.Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis 2003;1 Suppl 1:Abstract number: OC084.
11. Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis 2005;3(2):227-229 (Pubitemid 41623606)
12. Thaler I, Brenner B. Efficacy of enoxaparin for improving pregnancy outcomes and uteroplacental blood flow in women with thrombophilia and recurrent pregnancy loss. American Journal of Obstetrics and Gynecology 2004;191(6 Suppl 1):S7.
13. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. Journal of Thrombosis and Haemostasis 2003;1:433-438
14. Grandone E, Brancaccio V, Colaizzo D, Sciannamé N, Pavone G, Di Minno G, et al.Preventing adverse obstetric outcomes in women with genetic thrombophilia. Fertility and Sterility 2002;78(2):371-375 (Pubitemid 34831739)
15. Gris JC, Neveu S, Tailland ML, Courtieu C, Mares P, Schved JF. Use of a low-molecular-weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity. Thrombosis and Haemostasis 1995;73(3):362-367
16. Gris JC, Mercier E, Quéré I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, et al.Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695-3699 (Pubitemid 38596284)
17. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003;327:368-372 (Pubitemid 37000069)
18. Ogasawara MS, Iinuma Y, Aoki K, Katano K, Ozaki Y, Suzumori K. Low-dose aspirin is effective for treatment of recurrent miscarriage in patients with decreased coagulation factor XII. Fertility and Sterility 2001;76(1):203-204 (Pubitemid 32600984)
19. Rai R, Backos M, Baxter N, Chilcott I, Regan L. Recurrent miscarriage-an aspirin a day?. Human Reproduction 2000;15(10):2220-2223
20. Reznikoff-Etievant MF, Cayol V, Zou GM, Abuaf N, Robert A, Johanet C, et al.Habitual abortions in 678 healthy patients: investigation and prevention. Human Reproduction 1999;14(8):2106-2109 (Pubitemid 29381253)
21. Sarig G, Aharon A, Lanir N, Goshen H, Drugan A, Blumenfeld Z, et al.Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications. Journal of Thrombosis and Haemostasis 2003;1 Suppl 1:Abstract number: OC083.
22. Sarto A, Rocha M, Geller M, Capmany C, Martinez M, Quintans C, et al.Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia. Medicina 2001;61(4):406-412 (Pubitemid 32861646)
23. Sorensen HT, Johnsen SP, Larsen H, Pedersen L, Nielsen GL, Moller M. Birth outcomes in pregnant women treated with low-molecular-weight heparin. Acta Obstetricia et Gynecologica Scandinavica 2000;79:655-659 (Pubitemid 30487550)
24. Tzafettas J, Mamopoulos A, Anapliotis A, Loufopoulos A, Psarra A, Klearchou N, et al.Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriage of unknown etiology. Clinical and Experimental Obstetrics and Gynecology 2002;29(4):267-270 (Pubitemid 36187936)
25. Younis JS, Ohel G, Brenner B, Haddad S, Lanir N, Ben-Ami M. The effect of thromboprophylaxis on pregnancy outcome in patients with recurrent pregnancy loss associated with factor V mutation. BJOG: an international journal of obstetrics and gynaecology 2000;107:415-419 (Pubitemid 30145386)
26. Middeldorp S. Aspirin and/or low molecular weight heparin for women with unexplained recurrent miscarriage and/or intra-uterine fetal death. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005).
27. Schleussner E. Effectiveness of dalteparin therapy as intervention in recurrent pregnancy loss. http://controlled-trials.com (accessed 15.02.2007).
28. Clark P. The Scottish pregnancy intervention study: the effect of low molecular weight heparin and aspirin therapy on recurrent pregnancy loss. National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006).
29. Rodgers M. Thrombophilia in pregnancy prophylaxis study (TIPPS). Ottawa Health Research Institute - http://www.ohri.ca (accessed 2002).
30. American College of Obstetricians and Gynaecologists. ACOG practice bulletin: management of recurrent early pregnancy loss. International Journal of Gynecology & Obstetrics 2002;78:179-190
31. Braekeleer M, Dao TN. Cytogenetic studies in couples experiencing repeated pregnancy losses. Human Reproduction 1990;5:519-528 (Pubitemid 20250614)
32. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Human Reproduction 1999;14:2868-2871 (Pubitemid 29520709)
33. Christiansen OB, Nybo Andersen A, Bosch E, Salim Daya S, Delves P, Hviid T, et al.Evidence-based investigations and treatments of recurrent pregnancy loss. Fertility and Sterility 2005;83:821-839 (Pubitemid 40501551)
34. Christiansen OB. Evidence-based investigations and treatments of recurrent pregnancy loss. Current Opinion in Obstetrics and Gynecology 2006;18:304-312 (Pubitemid 43864731)
35. Clarke M, Oxman AD. Cochrane Reviewers' Handbook 4.1.5 [updated April 2002]. In: The Cochrane Library. Issue 2, 2002. Oxford: Updated Software. updated quarterly.
36. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Human Reproduction 1994;9:1328-1332 (Pubitemid 24224005)
37. Cook CL, Pridman DD. Recurrent pregnancy loss. Current Opinion in Obstetrics and Gynecology 1995;7:357-366
38. Dizon TD, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. American Journal of Obstetrics and Gynecology 1997;177:402-405 (Pubitemid 27385720)
39. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database of Systematic Reviews 2005, Issue 2. [Art. No.: CD002859. DOI: 10.1002/14651858.CD002859.pub2]
40. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997;315:32-34 (Pubitemid 27271683)
41. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstetrics & Gynecology 2002;100:408-413 (Pubitemid 35246124)
42. Franssen MT, Korevaar JC, Leschot NJ, Bossuyt PM, Knegt AC, Gerssen-Schoorl KB, et al.Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ 2005;331:137-141
43. Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119(Suppl):122-131
44. Goyaux N, Alihonou E, Diadhiou F, Leke R, Thonneau PF. Complications of induced abortion and miscarriage in three African Countries: a hospital-based study among WHO collaborating centres. Acta Obstetricia et Gynecologica Scandinavica 2001;80:568-573 (Pubitemid 32521299)
45. Haas DM, Ramsey PS. Progestogen for preventing miscarriage. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD003511. pub2]
46. Huisjes HJ. Spontaneous abortion. London: Churchill Livingstone, 1984:6.
47. Infante-Reviard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. New England Journal of Medicine 1991;325:1063-1066
48. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Human Reproduction 2006;21:2216-2222 (Pubitemid 44530592)
49. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al.Increased frequency of genetic thrombophilia in women with complications of pregnancy. New England Journal of Medicine 1999;340:9-13. (Pubitemid 29024678)
50. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. American Journal of Obstetrics and Gynecology 1996;174:1584-1589 (Pubitemid 26165282)
51. Lee C, Slade P. Miscarriage as a traumatic event: a review of the literature and new implications for intervention. Journal of Psychosomatic Research 1996;40(3):235-244 (Pubitemid 26118821)
52. Levine JS, Branch W, Rauch J. The antiphospholipid syndrome. New England Journal of Medicine 2002;346:752-763
53. Lindqvist PG, Merlo J. The natural course of women with recurrent fetal loss. Journal of Thrombosis and Haemostasis 2006;4:896-897
54. Lockshin MD. Pregnancy loss in the antiphospholipid syndrome. Thrombosis and Haemostasis 1999;82:641-648
55. Meinardi JR, Middeldorp S, de Kam PJ, Koopman MMW, van Pampus ECM, Hamulyak K, et al.Increased risk for fetal loss in carriers of the factor V Leiden. Annals of Internal Medicine 1999;130:736-739 (Pubitemid 29211511)
56. Middeldorp S. Thrombophilia and pregnancy complications: cause or association?. Journal of Thrombosis and Haemostasis 2007;5 Suppl 1:276-282
57. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?. Human Reproduction 2000;15:1830-1833 (Pubitemid 30636078)
58. National Health and Medical Research Council. Report on Maternal Deaths in Australia 1994-1996. Canberra. Australian Institute of Health and Welfare National Perinatal Statistics Unit, 2001.
59. Ankum WM, Erwich JJHM, Geraedts JPM, Goddijn M, Land JA, Macklon NS, et al.Recurrent miscarriage (dutch: herhaalde miskraam). www.nvog.nl (Dutch obstetrics & gynaecology guidelines) 08-106-2007.
60. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews 2006, Issue 2. [Art. No.: CD000112. DOI: 10.1002/14651858.CD000112.pub2]
61. Preston F, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al.Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-916 (Pubitemid 26333847)
62. Rai RS, Regan L, Clifford K, Pickering W, Dave M, Mackie I, et al.Antiphospholipid antibodies and beta2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive approach. Human Reproduction 1995;10:2001-2005
63. Rai RS, Regan L, Chitolie A, Donald JG, Cohen H. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance. British Journal of Obstetrics and Gynaecology 1996;103:842-844 (Pubitemid 26291767)
64. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:253-257 (Pubitemid 27047378)
65. Regan L. A prospective study of spontaneous abortion. Early pregnancy loss: mechanisms and treatment. RCOG, 1988.
66. The Cochrane Collaboration. Review Manager (RevMan). 4.1 for Windows. Oxford, England: The Cochrane Collaboration, 2000.
67. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-908 (Pubitemid 36335814)
68. Rushton DI. Placental pathology in spontaneous miscarriage. In: Beard RW, Sharp F editor(s). Early pregnancy loss: mechanisms and treatment. London: RCOG, 1988:149-158
69. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Huisman MV, Girolami A, et al.The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thrombosis and Haemostasis 1996;75(3):387-388 (Pubitemid 26099698)
70. Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E. Safety of low-molecular-weight heparin in pregnancy. A systematic review. Thrombosis and Haemostasis 1999;81:668-672 (Pubitemid 29216546)
71. Stirrat GM. Recurrent miscarriage: definition and epidemiology. Lancet 1990;336:673-675
72. Walker MC, Ferguson SE, Allen VM. Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database of Systematic Reviews 2003, Issue 2. [Art. No.: CD003580. DOI: 10.1002/14651858.CD003580]
73. World Health Organization. Recommended definitions; terminology and format for statistical tables related to the perinatal period. Acta Obstetricia et Gynecologica Scandinavica 1977;56:246-253
74. Di Nisio M, Peters LW, Middeldorp S. Aspirin or anticoagulants for the treatment of recurrent miscarriage in women without antiphospholipid syndrome. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD004734.pub2]